Left Ventricular Assist Devices for destination therapy in end-stage heart failure: The REMATCH trial

被引：0
|
作者：
Farrar, DJ [1 ]
机构：
[1] Thoratec Corp, Pleasanton, CA USA
来源：
SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW TECHNOLOGIES | 2002年
关键词：
LVAD; mechanical circulatory support; optimal medical therapy; end-stage congestive heart failure;
D O I：
暂无
中图分类号：
TP18 [人工智能理论];
学科分类号：
081104 ; 0812 ; 0835 ; 1405 ;
摘要：
Patients in end-stage heart failure who were not eligible for heart transplantation were randomized in the REMATCH study (Randomized Evaluation of Mechanical Assistance in the Treatment of Congestive Heart failure) to receive either the Heartmate VE Left Ventricular Assist Device (LVAD) or optimal medical management (OMM) over a two year period. Only 25% of patients who received OMM were alive after one year, confirming the advanced nature of their heart failure. With LVAD therapy, there was a doubling of survival at one year and improved quality of life. The Heartmate Left Ventricular Assist System provides an acceptable alternative therapy with a meaningful survival benefit in selected patients who are not candidates for heart transplantation.
引用
收藏
页码：1556 / 1557
页数：2
相关论文
共 50 条
  • [1] Left ventricular assist devices as destination therapy for end-stage heart failure
    Yager, JEE
    Felker, GM
    [J]. AMERICAN HEART JOURNAL, 2004, 148 (02) : 252 - 253
  • [2] Left ventricular assist devices as destination therapy for end-stage heart failure
    Stevenson L.W.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2004, 6 (6) : 471 - 479
  • [3] Left ventricular assist devices: an alternative to medical therapy for end-stage heart failure
    Radovancevic, B
    Vrtovec, B
    Frazier, OH
    [J]. CURRENT OPINION IN CARDIOLOGY, 2003, 18 (03) : 210 - 214
  • [4] The Use of Left Ventricular Assist Devices in End-Stage Heart Failure
    Blair, Ashley
    [J]. CRITICAL CARE NURSING QUARTERLY, 2018, 41 (04) : 376 - 382
  • [5] Left ventricular assist devices as destination therapy in stage D heart failure
    Rabea Asleh
    Sarah S.Schettle
    Fazal W.Khan
    Sudhir S.Kushwaha
    [J]. Journal of Geriatric Cardiology, 2019, 16 (08) : 592 - 600
  • [6] Left ventricular assist devices as destination therapy in stage D heart failure
    Asleh, Rabea
    Schettle, Sarah S.
    Khan, Fazal W.
    Kushwaha, Sudhir S.
    [J]. JOURNAL OF GERIATRIC CARDIOLOGY, 2019, 16 (08) : 592 - 600
  • [7] Left ventricular assist devices as destination therapy in stage D heart failure
    Rabea Asleh
    Sarah S.Schettle
    Fazal W.Khan
    Sudhir S.Kushwaha
    [J]. Journal of Geriatric Cardiology, 2019, 16 (08) : 592 - 600
  • [8] Combined Surgical Left Ventricular Reconstruction and Left Ventricular Assist Device Implantation for Destination Therapy in End-Stage Heart Failure
    Garbade, Jens
    Bittner, Hartmuth B.
    Barten, Markus J.
    Rastan, Ardawan
    Lehmann, Sven
    Mohr, Friedrich-Wilhelm
    Borger, Michael Andrew
    [J]. CIRCULATION-HEART FAILURE, 2011, 4 (04) : E14 - +
  • [9] Caring for a spouse with end-stage heart failure through implantation of a left ventricular assist device as a destination therapy
    Alkhuja, Samer
    Gazizov, Natalya
    Alexander, Mary Ellen
    [J]. HEART & LUNG, 2013, 42 (05): : 389 - 390
  • [10] First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure
    Esmore, DS
    Kaye, D
    Salamonsen, R
    Buckland, M
    Rowland, M
    Negri, J
    Rowley, Y
    Woodard, J
    Begg, JR
    Ayre, P
    Rosenfeldt, FL
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (08): : 1150 - 1154
12345